NCT03192449View on ClinicalTrials.gov

Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 21, 2016

Primary Completion Date

December 15, 2016

Study Completion Date

January 20, 2017

Conditions
Soil Transmitted HelminthiasisNeglected Tropical Diseases
Interventions
DRUG

Albendazole.

Single dose 400mg orally

All Listed Sponsors
collaborator

CIVETAN CONICET, Facultad de Ciencias Veterinarias, UNCPBA. Tandil

UNKNOWN

lead

Universidad Nacional de Salta

OTHER

NCT03192449 - Serum Pharmacokinetic Disposition and Urinary Excretion of Albendazole | Biotech Hunter | Biotech Hunter